ChargePoint’s own Chris Eccles spoke to World Pharma Today about the impact that the COVID-19 pandemic has had on the pharmaceutical industry.
Discussing several topics ranging from the increase in remote working for those in the industry freeing up space for on-site manufacturing, continued growing collaboration between drug manufacturers and their equipment partners to keep up with demand, and the on-shoring of supplies of raw materials for many pharmaceutical manufacturers to reduce the risk of shortages in future, Chris looks at how COVID-19 is shaping the future of pharma.
